An observational study in Sepsis and HBP, sponsored by Ain Shams University. Completed at 1 site in Egypt. Open to participants aged 20 Years to 70 Years. Per ClinicalTrials.gov, last updated 2022-11-08.
Sponsored by Ain Shams University · Observational
the aim of the study is to correlate between the severity of sepsis and serum heparin binding protein in the patients admitted to ICU with sepsis., and detect its value as a prognostic biomarker in sepsis
1,899 studies on the registry are indexed under Sepsis; 462 are open to participants now.
This study's enrollment of 55 is below the median of 160 across 931 observational studies indexed under Sepsis.
Browse Sepsis studies →Ain Shams University is the lead sponsor of 1,876 studies on the registry; 423 are open to participants now.
Of its 32 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
adult confirmed septic patients
Exclusion Criteria:
Evaluate the level of Heparin binding protein in relation to patient clinical improvement measured by SOFA Score
Correlates the change of the level of Heparin binding protein in ng/ml to the clinical improvement of the patients which is measured by SOFA score
Time frame: 72 hours after meeting sepsis ceriteria
Heparin binding protein and mortality
Correlates the change of the level of Heparin binding protein in ng/ml And how can it is used to predict mortality
Time frame: 28 days after meeting sepsis ceriteria
This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ain Shams University